These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18937212)

  • 1. NF-kappaB in liver diseases: a target for drug therapy.
    Muriel P
    J Appl Toxicol; 2009 Mar; 29(2):91-100. PubMed ID: 18937212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of in vivo nuclear factor-kappaB activation during liver inflammation in mice: prevention by catalase delivery.
    Hyoudou K; Nishikawa M; Kobayashi Y; Kuramoto Y; Yamashita F; Hashida M
    Mol Pharmacol; 2007 Feb; 71(2):446-53. PubMed ID: 17105872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
    Yates LL; Górecki DC
    Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of granulocyte apoptosis by NF-kappaB.
    Ward C; Walker A; Dransfield I; Haslett C; Rossi AG
    Biochem Soc Trans; 2004 Jun; 32(Pt3):465-7. PubMed ID: 15157161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contradictory functions of NF-kappaB in liver physiology and cancer.
    Vainer GW; Pikarsky E; Ben-Neriah Y
    Cancer Lett; 2008 Aug; 267(2):182-8. PubMed ID: 18479806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resolution of inflammation: anti-inflammatory roles for NF-kappaB.
    Lawrence T; Fong C
    Int J Biochem Cell Biol; 2010 Apr; 42(4):519-23. PubMed ID: 20026420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKKalpha in the regulation of inflammation and adaptive immunity.
    Lawrence T; Bebien M
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):270-2. PubMed ID: 17371257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
    Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
    Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
    Elsharkawy AM; Mann DA
    Hepatology; 2007 Aug; 46(2):590-7. PubMed ID: 17661407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dimethyl sulfoxide, pyrrolidine dithiocarbamate, and methylprednisolone on nuclear factor-kappaB and heat shock protein 70 in a rat model of hemorrhagic shock.
    Bini R; Olivero G; Trombetta A; Castagna E; Cotogni P
    J Trauma; 2008 Apr; 64(4):1048-54. PubMed ID: 18404074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
    Zhang Z; Rigas B
    Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
    Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
    Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.
    Horst D; Budczies J; Brabletz T; Kirchner T; Hlubek F
    Cancer; 2009 Nov; 115(21):4946-58. PubMed ID: 19658179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB and inflammation in genetic disease.
    Sebban H; Courtois G
    Biochem Pharmacol; 2006 Oct; 72(9):1153-60. PubMed ID: 16965764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage.
    Ma CX; Yin WN; Cai BW; Wu J; Wang JY; He M; Sun H; Ding JL; You C
    Chin Med J (Engl); 2009 Jul; 122(13):1575-81. PubMed ID: 19719951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.